PORTFOLIO NEWS NGM Bio Provides Business Update and Reports First Quarter 2020 Financial Results May 13, 2020 Read More » Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights May 7, 2020 Read More » Constellation Pharmaceuticals Announces First-Quarter 2020 Financial Results May 6, 2020 Read More » Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates May 5, 2020 Read More » ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares April 28, 2020 Read More » Ribon Therapeutics Presents Preclinical Data from its PARP7 and PARP14 Programs at AACR Virtual Meeting I April 27, 2020 Read More » Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins April 23, 2020 Read More » RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update March 30, 2020 Read More » Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology March 30, 2020 Read More » Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis March 25, 2020 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
NGM Bio Provides Business Update and Reports First Quarter 2020 Financial Results May 13, 2020 Read More »
Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights May 7, 2020 Read More »
Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates May 5, 2020 Read More »
ORIC Pharmaceuticals Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares April 28, 2020 Read More »
Ribon Therapeutics Presents Preclinical Data from its PARP7 and PARP14 Programs at AACR Virtual Meeting I April 27, 2020 Read More »
Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins April 23, 2020 Read More »
RAPT Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Business Update March 30, 2020 Read More »
Surrozen Announces Publication of Antibody Platform Technology in Cell Chemical Biology March 30, 2020 Read More »
Kallyope Inc. Announces $112M Series C Financing to Support First Clinical Trials and Advance Portfolio of Programs Targeting the Gut-Brain Axis March 25, 2020 Read More »
